Skip to main content
. 2020 Sep 1;6(3):163–169. doi: 10.5114/ceh.2020.98606

Table 3.

Recommended therapies and their duration

Pan-genotypic therapies GT1a GT1b GT2 GT3 GT4 GT5 GT6
GLE/PIB 8-12 weeks 8-12 weeks 8-12 weeks 8-16 weeks 8-12 weeks 8-12 weeks 8-12 weeks
SOF/VEL/VOX 8-12 weeks 8-12 weeks 8-12 weeks 8-12 weeks 8-12 weeks 8-12 weeks 8-12 weeks
SOF/VEL ± RBV 12-24 weeks 12-24 weeks 12-24 weeks 12-24 weeks 12-24 weeks 12-24 weeks 12-24 weeks